Leading CMO purchases multiple GMP scale twin-column units
Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production.
Previous Article
FDA purchases YMC technology Related Posts

June 18, 2026
Happy Retirement, John!
Today, we are celebrating John Heffernan, who is officially stepping into retirement after 16 years with YMC America.
John’s journey with us actually began back when we were known as Integrated Process Technologies, long before we transitioned to YMC America. Over the years, John has worn many hats, from Project Manager to Estimating Manager, Engineering Manager, and ultimately Director of Business Development.

June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.

May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
